Parliamentary Search

Written question asked by Cat Smith (Labour) on Thursday, 29 June 2023, in the House of Commons. It was due for an answer on Monday, 3 July 2023. It was answered by Neil O'Brien (Conservative) on Monday, 10 July 2023 on behalf of the Department of Health and Social Care.

Prescription Drugs: Misuse

Question

To ask the Secretary of State for Health and Social Care, with reference to the report by NHS England entitled Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: framework for action for integrated care boards and primary care, published in March 2023, what plans he has to assess the effectiveness of that framework for action.

Answer

The Department does not collect data on levels of dependence on and treatment for dependence on prescribed drugs. The National Institute for Health and Care Excellence (NICE) has published a range of evidence-based guidance that includes recommendations for the National Health Service on the use of benzodiazepines, z drugs and anti-depressants based on an assessment of their benefits and longer-term health impacts. The guidance ‘Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults’ which is available at the following link:

www.nice.org.uk/guidance/ng215

The Department has no current plans to assess the publication’s effectiveness of ‘Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care’.

Secondary information

Type
Written question
Reference
191815
Session
2022-23
Grouped for answer
Yes
Subjects
Prescription drugs Misuse
Link
View this Written question on www.parliament.uk